ARCHIVES

Higher Response For Gleevec In Trial; CML Patients Allowed To Switch

This article is from The Cancer Letter archive.

Vol. 25 No. 1 | January 25, 2002

Download PDF Visit The Full Archive

Related Articles

Cancer Panel: Lack Of Genetic Basis For Race Presents Dilemma For Studies; Data Collection Must Include Socioeconomic Measures, Report To Clinton Says

March 20, 1998

UCSF Wins $500,000 Grant From Bristol-Myers Squibb Foundation

March 15, 2002

NCCN and Pfizer Issue RFP In Renal Cell Carcinoma Or Hematologic Malignancies

October 25, 2013

Onward to 2010? NCI promises faster progress for more money.

May 20, 2005

NIH On R29 Phase-Out; Grant Review Appeals Process Changed

January 23, 1998

AHCPR Funds Centers to Review Practice

July 4, 1997